Cholinergic changes in the hippocampus of stroke-prone spontaneously hypertensive rats
- PMID: 8610323
- DOI: 10.1161/01.str.27.3.520
Cholinergic changes in the hippocampus of stroke-prone spontaneously hypertensive rats
Abstract
Background and purpose: We investigated age-related changes in the central cholinergic systems in stroke-prone spontaneously hypertensive rats (SHRSP) to examine whether the regional and progressive cholinergic changes occur and are correlated with behavioral changes in the passive avoidance task.
Methods: Tissue levels of choline (Ch) and acetylcholine (ACh) were determined in the cerebral regions, including the hippocampus, of SHRSP (at two ages: 15 to 20 and 30 to 40 weeks) that had been tested in a passive avoidance task and were compared with those of age-matched controls, Wistar-Kyoto rats (WKY). With the use of in vivo microdialysis, high K+-stimulated release of hippocampal ACh, a functional parameter of the cholinergic system, was also determined in 15- to 20-week-old SHRSP.
Results: We found that 15- to 20-week-old SHRSP demonstrated a markedly lower level of hippocampal Ch than age-matched WKY. The decrease in the Ch level in 15- to 20-week-old SHRSP was observed in all regions examined; however, in the hippocampus a significant difference from WKY was subsequently observed at the age of 30 to 40 weeks. The hippocampal ACh release was markedly decreased by repetitive stimulation with high K+ in 15- to 20-week-old SHRSP. Behavioral impairment in the passive avoidance task was observed in the two age groups of SHRSP, with significant and positive correlations between the hippocampal ACh levels and the response latency.
Conclusions: A decrease in hippocampal Ch level was observed in both 15- to 20-week-old and 30- to 40-week-old SHRSP, accompanied by performance failure in the passive avoidance task. The abnormal release of hippocampal ACh in response to the repetitive K+ stimulation was also noted in 15- to 20-week-old SHRSP. Thus, cholinergic dysfunction in the hippocampal system may be responsible for behavioral abnormality in the passive avoidance task in SHRSP.
Similar articles
-
Dietary docosahexaenoic acid increases cerebral acetylcholine levels and improves passive avoidance performance in stroke-prone spontaneously hypertensive rats.Pharmacol Biochem Behav. 1997 Dec;58(4):1123-9. doi: 10.1016/s0091-3057(97)00300-6. Pharmacol Biochem Behav. 1997. PMID: 9408223
-
Pathogenesis of vascular dementia in stroke-prone spontaneously hypertensive rats.Toxicology. 2000 Nov 16;153(1-3):167-78. doi: 10.1016/s0300-483x(00)00312-7. Toxicology. 2000. PMID: 11090955
-
Alteration in Ca2+/calmodulin-sensitive adenylyl cyclase activity in the hippocampus of stroke-prone spontaneously hypertensive rats.Life Sci. 1998;62(17-18):1683-8. doi: 10.1016/s0024-3205(98)00128-3. Life Sci. 1998. PMID: 9585157
-
[Antihypertensive effect of docosahexaenoic acid in stroke-prone spontaneously hypertensive rats].Yakugaku Zasshi. 2000 Jul;120(7):607-19. doi: 10.1248/yakushi1947.120.7_607. Yakugaku Zasshi. 2000. PMID: 10920715 Review. Japanese.
-
Cholinergic modulation of the hippocampal region and memory function.J Neurochem. 2017 Aug;142 Suppl 2(Suppl 2):111-121. doi: 10.1111/jnc.14052. J Neurochem. 2017. PMID: 28791706 Free PMC article. Review.
Cited by
-
Comparative analysis of the persistence of a conditioned passive avoidance reflex in rats with different forms of inherited hypertension.Neurosci Behav Physiol. 2007 Jul;37(6):577-82. doi: 10.1007/s11055-007-0055-y. Neurosci Behav Physiol. 2007. PMID: 17657428
-
Small Vessel Disease-Related Dementia: An Invalid Neurovascular Coupling?Int J Mol Sci. 2020 Feb 7;21(3):1095. doi: 10.3390/ijms21031095. Int J Mol Sci. 2020. PMID: 32046035 Free PMC article. Review.
-
Galantamine in the treatment of cognitive decline in patients with vascular dementia or Alzheimer's disease with cerebrovascular disease.CNS Drugs. 2003;17(12):905-14. doi: 10.2165/00023210-200317120-00004. CNS Drugs. 2003. PMID: 12962529 Clinical Trial.
-
Risk factors for vascular dementia: hypotension as a key point.Vasc Health Risk Manag. 2008;4(2):395-402. doi: 10.2147/vhrm.s2434. Vasc Health Risk Manag. 2008. PMID: 18561514 Free PMC article. Review.
-
Cholinesterase inhibitors and vascular dementia: another string to their bow?CNS Drugs. 2004;18(2):79-92. doi: 10.2165/00023210-200418020-00002. CNS Drugs. 2004. PMID: 14728055 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical